Letters

May 8, 2013 | Letter
Excerpt: FDA stated that the information USPlabs submitted was ‘insufficient to defend the use of DMAA as an ingredient in dietary supplements’ and advised consumers not to buy or use any products containing the stimulant. FDA subsequently asserted that it could ban an unsafe ingredient in a dietary supplement, though the agency is required to ‘undertake a series of lengthy scientific and legal steps’ in doing so.
May 3, 2013 | Letter
Excerpt: We write in strong support of the Food and Drug Administration's (FDA) announcement to apply a "removed for safety or efficacy" determination to the crushabale form of OxyContin. This decision by FDA will help mitigate the harmful effects of the nation's prescription drug abuse crisis. inculding the suffering it causes in families across our country.
April 29, 2013 | Letter
Excerpt: Unfortunately, based on Committee staff’s review of the redacted annual loan reviews for each project, it appears that these job estimates have failed to materialize, in part, due to the aforementioned bankruptcies and the precarious financial positions of certain other projects. Despite these changing conditions, however, the estimated number of jobs preserved or created by the Section 1705 program, as advertised on the DOE website, has unexpectedly remained the same.
April 25, 2013 | Letter
Excerpt: DOE now is 15 years behind schedule in taking custody of commercial used nuclear fuel. As a result, utilities have been storing the used fuel on the sites where it was generated. Utilities have filed lawsuits seeking to recover from the federal government the costs incurred.
April 19, 2013 | Letter
Excerpt: When Congress authorized the Commission in the Spectrum Act to conduct an incentive auction of broadcast spectrum, we had several goals in mind.  We certainly wanted the Commission to design an auction that would make more spectrum available to wireless carriers to meet soaring demand for mobile broadband use.
April 19, 2013 | Letter
To read the letter relating to LG Chem, click here. To read the letter relating to Fisker Automotive, Inc., click here.

Pages